Pharmaceutical residues in wastewater treatment works effluents and their impact on receiving river water

Journal of Hazardous Materials

Volumn 166, Issue 2-3, 2009, Pages 655-661

  Zhou, J L ^a   Zhang, Z L ^a   Banks, E ^a   Grover, D ^a   Jiang, J Q ^b  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

^b UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

Dilution; Liquid chromatography tandem mass spectrometry; Pharmaceuticals; River; Wastewater

Indexed keywords

CARBAMAZEPINE; DICLOFENAC; DILUTION MODELS; ENGLAND; ENVIRONMENTAL RISK ASSESSMENTS; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; PHARMACEUTICAL COMPOUNDS; PHARMACEUTICAL RESIDUES; PHARMACEUTICALS; RIVER WATER QUALITIES; RIVER WATER SAMPLES; RIVER WATERS; SAND FILTRATIONS; SULFAMETHOXAZOLE; TERTIARY TREATMENTS; WASTEWATER TREATMENT WORKS;

AMIDES; BIOCHEMICAL OXYGEN DEMAND; CHROMATOGRAPHIC ANALYSIS; CONCENTRATION (PROCESS); DRUG PRODUCTS; EFFLUENTS; ENVIRONMENTAL IMPACT ASSESSMENTS; LIQUID CHROMATOGRAPHY; LIQUIDS; MASS SPECTROMETERS; MASS SPECTROMETRY; RISK ASSESSMENT; RISK MANAGEMENT; RIVERS; SPECTRUM ANALYSIS; WASTEWATER; WASTEWATER RECLAMATION; WATER POLLUTION; WATER QUALITY; WATER RECYCLING; WATER TREATMENT PLANTS;

WASTEWATER TREATMENT;

CARBAMAZEPINE; DICLOFENAC; INDOMETACIN; PROPRANOLOL; RIVER WATER; SULFAMETHOXAZOLE;

CONCENTRATION (COMPOSITION); DILUTION; DISCHARGE; DRUG; EFFLUENT; ENVIRONMENTAL RISK; RISK ASSESSMENT; RIVER WATER; WASTEWATER; WATER TREATMENT;

ARTICLE; CONCENTRATION (PARAMETERS); DILUTION; DRUG INDUSTRY; EFFLUENT; FILTRATION; LIQUID CHROMATOGRAPHY; RISK ASSESSMENT; RIVER; SAND; TANDEM MASS SPECTROMETRY; UNITED KINGDOM; WASTE WATER MANAGEMENT; WATER QUALITY; WATER SAMPLING;

CARBAMAZEPINE; DICLOFENAC; GREAT BRITAIN; INDOMETHACIN; PHARMACEUTICAL PREPARATIONS; PROPRANOLOL; RIVERS; SULFAMETHOXAZOLE; WATER POLLUTANTS, CHEMICAL;

ENGLAND; EURASIA; EUROPE; UNITED KINGDOM; WESTERN EUROPE;

EID: 67349241971     PISSN: 03043894     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhazmat.2008.11.070     Document Type: Article

References (23)

1. Ternes T.A. Occurrence of drugs in German sewage treatment plants and rivers. Water Res. 32 (1998) 3245-3260
2. Heberer T. Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. Toxicol. Lett. 131 (2002) 5-17
3. Fent K., Weston A.A., and Caminada D. Review: ecotoxicology of human pharmaceuticals. Aquat. Toxicol. 76 (2006) 122-159
4. Nikolaou A., Meric S., and Fatta D. Occurrence patterns of pharmaceuticals in water and wastewater environments. Anal. Bioanal. Chem. 387 (2007) 1225-1234
5. Oaks J.L., Gilbert M., Virani M.Z., Watson R.T., Meteyer C.U., Rideout B.A., Shivaprasad H.L., Ahmed S., Chaudhry M.J.I., Arshad M., Mahmood S., Ali A., and Khan A.A. Diclofenac residues as the cause of vulture population decline in Pakistan. Nature 427 (2004) 630-633
6. Hong H.N., Kim H.N., Park K.S., Lee S., and Gu M.B. Analysis of the effects diclofenac has on Japanese medaka (Oryzias latipes) using real-time PCR. Chemosphere 67 (2007) 2115-2121
7. In: Kummerer K. (Ed). Pharmaceuticals in the Environment-Sources, Fate, Effects and Risks. 2nd ed. (2004), Springer, Berlin
8. Ashton D., Hilton M., and Thomas K.V. Investigating the environmental transport of human pharmaceuticals to streams in the United Kingdom. Sci. Total Environ. 333 (2004) 167-184
9. Zhang Z.L., and Zhou J.L. Simultaneous determination of various pharmaceutical compounds in waters by solid phase extraction-liquid chromatography tandem mass spectrometry. J. Chromatogr. A 1154 (2007) 205-213
10. Bendz D., Paxeus N.A., Ginn T.R., and Logec F.J. Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Hoje River in Sweden. J. Hazard. Mater. 122 (2005) 195-204
11. Kasprzyk-Hordern B., Dinsdale R.M., and Guwy A.J. Multiresidue methods for the analysis of pharmaceuticals, personal care products and illicit drugs in surface water and wastewater by solid-phase extraction and ultra performance liquid chromatography-electrospray tandem mass spectrometry. Anal. Bioanal. Chem. 391 (2008) 1293-1308
12. Miao X.-S., Bishay F., Chen M., and Metcalfe C.D. Occurrence of antimicrobials in the final effluents of wastewater treatment plants in Canada. Environ. Sci. Technol. 38 (2004) 3533-3541
13. Spongberg A.L., and Witter J.D. Pharmaceutical compounds in the wastewater process stream in Northwest Ohio. Sci. Total Environ. 397 (2008) 148-157
14. Kimura K., Hara H., and Watanabe Y. Elimination of selected acidic pharmaceuticals from municipal wastewater by an activated sludge system and membrane bioreactors. Environ. Sci. Technol. 41 (2007) 3708-3714
15. Jones O.A.H., Voulvoulis N., and Lester J.N. The occurrence and removal of selected pharmaceutical compounds in a sewage treatment works utilising activated sludge treatment. Environ. Pollut. 145 (2007) 738-744
16. Zhang Z., Hibberd A., and Zhou J.L. Analysis of emerging contaminants in sewage effluent and river water: comparison between spot and passive sampling. Anal. Chim. Acta 607 (2008) 37-44
17. Batt A.L., Kostich M.S., and Lazorchak J.M. Analysis of ecologically relevant pharmaceuticals in wastewater and surface water using selective solid-phase extraction and UPLC-MS/MS. Anal. Chem. 80 (2008) 5021-5030
18. Chen H.C., Wang P.L., and Ding W.H. Using liquid chromatography-ion trap mass spectrometry to determine pharmaceutical residues in Taiwanese rivers and wastewaters. Chemosphere 72 (2008) 863-869
19. Stumpf M., Ternes T.A., Wilken R.D., Rodrigues S.W., and Baumann W. Polar drug residues in sewage and natural waters in the state of Rio de Janeiro, Brazil. Sci. Total Environ. 225 (1999) 135-141
20. Ternes T.A., Meisenheimer M., Mcdowell D., Sacher F., Brauch H.J., Haist-Gulde B., Preuss G., Wilme U., and Zulei-Seibert N. Removal of pharmaceuticals during drinking water treatment. Environ. Sci. Technol. 36 (2002) 3855-3863
21. Cleuvers M. Aquatic ecotoxicity of pharmaceuticals including the assessment of combination effects. Toxicol. Lett. 142 (2003) 185-194
22. Flaherty C.M., and Dodson S.I. Effects of pharmaceuticals on Daphnia survival, growth, and reproduction. Chemosphere 61 (2005) 200-207
23. Triebskorn R., Casper H., Scheil V., and Schwaiger J. Ultrastructural effects of pharmaceuticals (carbamazepine, clofibric acid, metoprolol, diclofenac) in rainbow trout (Oncorhynchus mykiss) and common carp (Cyprinus carpio). Anal. Bioanal. Chem. 387 (2007) 1405-1416